The Board of Directors of AMAG Pharmaceuticals, Inc. has authorized a buyback plan on January 6, 2016.
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+40.15% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.48% | 234B | |
+16.57% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
The Board of Directors of AMAG Pharmaceuticals, Inc. has authorized a buyback plan on January 6, 2016.
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+40.15% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.48% | 234B | |
+16.57% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |